A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity.
Saved in:
| Title: | A TAK1 cytokine toxicity checkpoint controls anti-cancer immunity. |
|---|---|
| Authors: | Djajawi TM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Huber A; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Rivera SM; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Srivaths A; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Salehi M; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Gunay G; Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland., Gerak C; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Neil L; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Ozaydin O; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Voulgaris O; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Al Halawani A; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Gannon D; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Khoshdoozmasouleh N; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Jenkins LJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Chan KF; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Behren A; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Ernst M; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Mielke LA; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Lelliott EJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Dong H; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Feltham R; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia., Sutton VR; The Peter MacCallum Cancer Centre, Parkville, VIC 3052, Australia., Trapani JA; The Peter MacCallum Cancer Centre, Parkville, VIC 3052, Australia., Mariadason JM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Pal B; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia., Martin SJ; Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland., Vervoort SJ; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia. Electronic address: vervoort.s@wehi.edu.au., Kearney CJ; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC 3086, Australia. Electronic address: conor.kearney@onjcri.org.au. |
| Source: | Cell reports [Cell Rep] 2026 Jan 27; Vol. 45 (1), pp. 116665. Date of Electronic Publication: 2025 Dec 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
